Captor Therapeutics Spolka Akcyjna

Warsaw Stock Exchange CTX.WA

Captor Therapeutics Spolka Akcyjna Net Cash Used For Investing Activities for the year ending December 31, 2023: USD 5.05 M

Captor Therapeutics Spolka Akcyjna Net Cash Used For Investing Activities is USD 5.05 M for the year ending December 31, 2023, a 225.61% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Captor Therapeutics Spolka Akcyjna Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -4.02 M, a -218.13% change year over year.
Captor Therapeutics Spolka Akcyjna Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -1.26 M, a -2,128.47% change year over year.
Captor Therapeutics Spolka Akcyjna Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -56.76 K, a 5.81% change year over year.
Captor Therapeutics Spolka Akcyjna Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -60.26 K, a -125.73% change year over year.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

Warsaw Stock Exchange: CTX.WA

Captor Therapeutics Spolka Akcyjna

CEO	Dr. Thomas Shepherd Ph.D.
IPO Date	April 1, 2021
Location	Poland
Headquarters	ul. Dunska 11
Employees	105
Sector	Healthcare
Industries Biotechnology Clinical Trials Pharmaceuticals Vaccines

Description

Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. It has five projects at the preclinical stage. The company was incorporated in 2015 and is based in Wroclaw, Poland.

Key trends

Past 5 years